Space Motion Sickness Countermeasures: A Pharmacological Double-Blind, Placebo-Controlled Study
Introduction: Space motion sickness (SMS), caused by a canal-otolith conflict, is currently treated with intramuscular promethazine. However, the drug has an inconsistent efficacy against SMS. We hypothesize that pharmacological depression of the semicircular canals (SCC) might relieve SMS. The aim of the present study was to identify the effects of meclizine (25 mg), dimenhydrinate (40 mg) combined with cinnarizine (25 mg), and promethazine (25 mg) combined with d-amphetamine (10 mg) on the SCCs and the otoliths. Methods: This double-blind, placebo-controlled study was performed on 20 healthy men. Function of the SCC was evaluated by means of an electronystagmography, whereas utricular function was assessed by a unilateral centrifugation test. A cervical vestibular evoked myogenic potentials test evaluated saccular function. Results: Meclizine (0.54 ± 0.05 vs. 0.38 ± 0.06) and dimenhydrinate with cinnarizine (0.54 ± 0.05 vs. 0.45 ± 0.05) decreased the vestibulo-ocular reflex gain. Promethazine with d-amphetamine decreased the latency of the saccadic eye response (right eye: 185 ± 3.8 ms vs. 165 ± 4.5 ms; left eye: 181 ± 4.9 ms vs. 165 ± 4.8 ms) and also increased the phase of ocular counterrolling measured during unilateral centrifugation (0.32 ± 0.35° vs. 1.5 ± 0.45°). Discussion: It is hypothesized that meclizine and dimenhydrinate with cinnarizine affect the medial vestibular nucleus. Promethazine is a vestibular suppressor, but study results show that d-amphetamine counterbalances this depression and abolishes the effect of fatigue on the saccadic reaction time The hypothesis that a SCC-suppression alleviates SMS should be further evaluated.
Document Type: Research Article
Affiliations: Antwerp University Research Center for Equilibrium and Aerospace (AUREA), the StatUA Center for Statistics, and the Department of Critical Care Medicine, Clinical Pharmacology, Antwerp University Hospital, University of Antwerp, Antwerp, Belgium
Publication date: 01 June 2014
- The peer-reviewed monthly journal, Aviation, Space, and Environmental Medicine (ASEM) provides contact with physicians, life scientists, bioengineers, and medical specialists working in both basic medical research and in its clinical applications. It is the most used and cited journal in its field. ASEM is distributed to more than 80 nations.
To access volumes 86 to present, please click here.
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Membership Information
- Information for Advertisers
- Submit Articles
- Ingenta Connect is not responsible for the content or availability of external websites